IRADIMED CORPORATION

IRMD ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $51.2M $52.2M $49.8M $58.0M $62.0M $50.1M $43.5M $28.0M
Accounts Receivable $13.7M $10.6M $12.2M $13.3M $5.1M $4.6M $7.3M $4.2M
Inventory $11.6M $10.4M $12.8M $5.4M $4.3M $3.9M $3.6M $4.1M
Total Current Assets $81.2M $75.2M $76.0M $77.5M $76.2M $63.7M $59.0M $44.5M
Property, Plant & Equipment $23.9M $16.8M $9.3M $2.4M $2.1M $2.1M $2.1M $1.9M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $3.4M $3.1M $2.5M $2.1M $1.1M $960.9K $860.1K $832.5K
Total Assets $108.8M $98.3M $92.2M $85.5M $82.9M $71.1M $66.7M $48.4M
Liabilities
Accounts Payable $1.8M $1.9M $1.9M $1.8M $782.9K $657.1K $993.7K $772.5K
Total Current Liabilities $10.2M $8.5M $16.3M $8.6M $6.8M $4.9M $5.9M $4.7M
Long-Term Debt — — — — — — — —
Total Liabilities $14.2M $11.5M $20.7M $11.8M $10.7M $9.7M $11.2M $6.5M
Stockholders' Equity
Retained Earnings $64.2M $56.8M $43.3M $47.3M $47.0M $37.7M $36.3M $26.7M
Total Stockholders' Equity $94.6M $86.8M $71.4M $73.7M $72.2M $61.4M $55.5M $41.9M
← Newer Page 1 of 2 Older →